Giving Consent to the Ineffable

Area of Science:

• Psychiatry and Mental Healthcare
• Bioethics

Background:

• A resurgence in psychedelic research and clinical application is occurring in mental health.
• Ethical considerations, particularly informed consent, are crucial for psychedelic-assisted therapy.
• The transformative potential of psychedelics raises questions about patient comprehension and value alignment.

Purpose of the Study:

• To address the ethical question of whether patients can give informed consent for psychedelic-assisted therapy.
• To evaluate if the transformative nature of psychedelic experiences impedes a patient's ability to consent.
• To assert that patients possess sufficient understanding for valid consent.

Main Methods:

• Philosophical argument and ethical analysis.
• Examination of the concept of informed consent in the context of novel therapeutic modalities.
• Analysis of patient motivation and understanding of treatment goals.

Main Results:

• Patients can provide informed consent for psychedelic-assisted therapy.
• The ability to consent is not invalidated by the inability to predict the specific subjective experience.
• Patients' desire to change a negative status quo and recognition of therapy's efficacy are key factors.

Conclusions:

• Informed consent for psychedelic-assisted therapy is achievable.
• Patients' understanding of their desire for change and the therapy's potential to facilitate it is sufficient for consent.
• Ethical frameworks must accommodate the unique nature of psychedelic-assisted mental healthcare.